ENDRA Life Sciences (NDRA) Other Non-Current Liabilities (2024 - 2026)

ENDRA Life Sciences (NDRA) has 3 years of Other Non-Current Liabilities data on file, last reported at $488604.0 in Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $488604.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $488604.0 (changed N/A YoY), and the FY2025 annual result was $479747.0, down 39.98% from the prior year.
• Other Non-Current Liabilities advanced to $488604.0 in Q1 2026 per NDRA's latest filing, from $479747.0 in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $799284.0 in Q4 2024 and troughed at $479747.0 in Q4 2025.
• A 3-year average of $590879.8 and a median of $542244.0 in 2025 frame the typical range for Other Non-Current Liabilities.
• On a YoY basis, Other Non-Current Liabilities climbed as much as 39.98% in 2025 and fell as far as 39.98% in 2025.
• A 3-year view of Other Non-Current Liabilities shows it stood at $799284.0 in 2024, then sank by 39.98% to $479747.0 in 2025, then advanced by 1.85% to $488604.0 in 2026.
• Business Quant data shows NDRA's Other Non-Current Liabilities at $488604.0 in Q1 2026, $479747.0 in Q4 2025, and $595884.0 in Q3 2025.